|
|
||||||||
J Thorac Cardiovasc Surg 2006;131:651-658
© 2006 The American Association for Thoracic Surgery
Cardiopulmonary Support and Physiology |
a Institut National de la Santé et de la Recherche Médicale, Faculté de Médecine de Créteil, Créteil, France
b Service de Chirurgie Thoracique et Cardiovasculaire, Hôpital Henri Mondor, Assistance Publique-Hôpitaux de Paris, Créteil, France
c Service de Réanimation Médicale, Hôpital Henri Mondor, Créteil, France
Received for publication May 5, 2005; revisions received August 19, 2005; accepted for publication August 26, 2005. * Address for reprints: Armand Mekontso-Dessap, MD, Service de Réanimation Médicale, Hôpital Henri Mondor, Avenue du Maréchal de Lattre de Tassigny, 94000 Créteil, France. (Email: armand.dessap{at}creteil.inserm.fr).
| Abstract |
|---|
|
|
|---|
METHODS: We evaluated the intimal thickening of the human graft segments in organ cultures (histopathology, morphometric, and immunofluorescence analyses) and assessed the properties of cultured smooth muscle cells isolated from these vessels in terms of cell proliferation (tritiated thymidine incorporation), migration (modified Boyden chamber), and collagen synthesis (tritiated proline incorporation).
RESULTS: The total vessel-wall growth index and the intimal growth index were significantly higher for saphenous vein rings than for radial artery and internal thoracic artery rings. Immunofluorescence analyses showed predominant involvement of smooth muscle cells in neointimal growth induced by organ culture of saphenous vein rings. Cell proliferation was significantly higher in saphenous vein smooth muscle cells than in radial artery smooth muscle cells and significantly higher in radial artery smooth muscle cells than in internal thoracic artery smooth muscle cells. Migration of smooth muscle cells from saphenous vein grafts was significantly greater than from internal thoracic artery or radial artery grafts. Collagen synthesis was similar in smooth muscle cells from internal thoracic artery, radial artery, and saphenous vein grafts.
CONCLUSIONS: Ex vivo vascular-wall remodeling and smooth muscle cell intrinsic growth and migratory properties are dissimilar between arterial and venous grafts and might shed light on reported angiographic patency rates of these grafts.
| Introduction |
|---|
|
|
|---|
|
Coronary heart disease is the most common cause of morbidity and mortality in industrialized countries. Coronary artery bypass grafting (CABG) with a combination of arterial and venous grafts is now a component of the standard treatment armamentarium for patients with coronary heart disease. CABG reduces both symptoms and mortality, particularly in patients with severe disease. However, its long-term benefits are dependent on continuing patency of the bypass conduits.
The long-term patency of saphenous vein (SV) grafts is limited, and approximately half of these conduits undergo occlusion within 10 years.
1
These late occlusions have been ascribed to neointimal hyperplasia (NIH), with an accumulation of smooth muscle cells (SMCs) and extracellular matrix in the graft intima. NIH narrows the graft lumen and sets the scene for subsequent graft atherosclerosis.
2
Compared with SV grafts, internal thoracic artery (ITA) grafts have yielded significantly better long-term results.
3
This has prompted a search for other reliable arterial conduits. The radial artery (RA) was introduced by Carpentier and colleagues in 1973 as an alternative bypass conduit for CABG. However, it was soon abandoned because of its high failure rate attributed to spasm of the denervated artery and NIH formation.
4,5
Nonetheless, improved harvesting techniques with avoidance of mechanical dilation, postoperative vasospasm prophylaxis, and appropriate grafting strategy have revived the radial artery as a conduit for coronary revascularization.
6
In fact, several groups have recently reported better long-term clinical and angiographic results than with SV grafts.
7-10
Given the pivotal role of SMCs in the pathogenesis of NIH and the well-established phenotypic heterogeneity of SMCs across vessels,
11
we hypothesized that differences in long-term graft patency are at least partly related to differences in SMC growth and migratory properties. To investigate this hypothesis, we compared the remodeling of human ITA, RA, and SV bypass conduits using 2 approaches. First, we evaluated the intimal thickening of the ITA, RA, and SV segments in organ cultures. Second, we studied the properties of cultured SMCs isolated from ITAs, RAs, and SVs in terms of cell proliferation, migration, and collagen synthesis.
| Methods |
|---|
|
|
|---|
Organ Culture, Histopathology, and Morphometric Analysis
After removal, the vessels were immediately immersed in Dulbecco's modified Eagle's medium (DMEM), placed at 4°C, and transferred to the laboratory within 24 hours. Two adjacent rings 5 to 8 mm in length were dissected from each vessel. The first ring (R1) was immediately fixed without being cultured and served as the control. The second ring (R2) was fixed after 10 days of incubation in cell-culture flasks containing DMEM supplemented with 10% fetal calf serum (FCS), 2 mmol/L L-glutamine, and antibiotics (100 U/mL penicillin and 0.1 mg/mL streptomycin) at 37°C in a 5% CO2 humidified atmosphere. The medium was changed every 2 days. For microscopic studies, vessel rings were fixed in 4% formaldehyde solution. Multiple transverse slides were processed in paraffin wax. Sections 5 µm in thickness were cut and stained with hematoxylin and eosin, elastic stain, and orcein-picroindigo-carmine. The slides were examined with a Charge-Coupled Device Iris camera (CDD Iris; Sony, Paris, France) coupled with an optical microscope (Laborlux, Wetzlar, Germany), and images were obtained with Perfect Image software (Clara Vision, Orsay, France). The total vessel wall area and the intimal area were measured on R1 and R2. The intima of ITAs and RAs was defined as the zone between the endothelium and the internal elastic lamina, and the intima of SVs was defined as the layer of tissue between the endothelium and the media. The vessel-wall growth index was used to compare preculture sections of each vessel with corresponding cultured sections and was computed as follows:
|
| (1) |
|
| (2) |
Immunofluorescence Analyses
Vessel sections were obtained and embedded in paraffin. Paraffin from 5-µm-thick sections was removed with xylene, and the sections were rehydrated through graded alcohol to water. Before labeling, the sections were permeabilized for 10 minutes in phosphate-buffered saline (PBS) containing 0.1% Triton. The sections were then blocked with PBS containing 5% bovine serum albumin for 1 hour. The sections were incubated for 1 hour at room temperature with mouse anti-
-smooth muscle actin antibody diluted 1:100, mouse anti-desmin antibody diluted 1:200, and mouse anti-vimentin antibody diluted 1:100, which are specific for SMCs.
12
After washing, the sections were incubated for 1 hour at room temperature with an anti-mouse (donkey) antibody conjugated with Cy3 diluted 1:400. After washing, the sections were mounted and examined under a Zeiss Axiovert microscope (Zeiss, Le Pecq, France). Control experiments with secondary antibody without primary antibody were also performed to determine nonspecific binding.
SMC Cultures
SMCs were cultured from explants, as previously described.
13
In brief, vessels were kept in DMEM at 4°C before their intimal cell layer and residual adventitial tissue were stripped off. The dissected media of the vessels was then cut into small pieces (3-5 mm), which were transferred into cell-culture flasks. The vessel tissues were incubated in DMEM supplemented with 10% FCS, 2 mmol/L L-glutamine, and antibiotics (100 U/mL penicillin and 0.1 mg/mL streptomycin) to allow the SMCs to grow out. After 2 weeks of incubation at 37°C and under a 5% CO2 humidified atmosphere, the SMCs collected in the culture medium, and the vessel tissues were transferred into new cell-culture flasks. Cultured SMCs were used for experiments between passages 1 to 3.
Measurement of SMC Proliferation
SMCs in DMEM supplemented with 10% FCS were seeded in 24-well plates at a density of 5 x 104 cells per well and allowed to adhere. The cells were then subjected to 48 hours of growth arrest in medium containing only 0.2% FCS and incubated in DMEM supplemented with 0.6 µCi/mL tritiated thymidine with 0.5%, 5%, or 10% FCS. After incubation for 24 hours, the cells were washed twice with PBS, treated with ice-cold 10% trichloroacetic acid (TCA), dissolved in 1N NaOH (0.5 mL/well), and neutralized with 75 µL of 12N HCl per well. The incorporated radioactivity was then counted with a liquid scintillation counter. All experiments were run in 6 replicates.
SMC Migration
SMC migration was evaluated with a modified Boyden chamber. A polycarbonate filter with an 8.0-µm pore diameter (Costar, Cambridge, United Kingdom) coated with 5 mg/L gelatin was used to divide the upper and lower well chambers. Cultured SMCs were trypsinized and suspended in a concentration of 5 x 104 cells/mL in culture medium containing 10% FCS. A volume of 0.2 mL of suspended cells was placed in the upper chamber, and 0.5 mL of the same culture medium was loaded in the lower chamber. After 24 hours of incubation (37°C at 5% CO2 in air) to allow cell adhesion, the upper chamber medium was replaced with serum-free culture medium, and the lower chamber medium was replaced with culture medium containing FCS (0.5% or 5%). After 24 hours of incubation, cells that had migrated to the bottom side of the filter were fixed with ethanol, stained with Diff Quick staining, and counted from 9 randomly chosen high-power (125x) fields. All experiments were run in duplicate.
Measurement of SMC Collagen Synthesis
Collagen synthesis was assessed on the basis of measurement of cellular tritiated proline uptake, as previously described.
14
Briefly, SMCs in DMEM supplemented with 10% FCS were seeded in 24-well plates at a density of 2 x 104 cells per well and allowed to adhere. The cells were then subjected to 48 hours of growth arrest in medium containing only 0.2% FCS and were then incubated in DMEM supplemented with 1 µCi/mL tritiated proline (L-[4-3H(N)]-proline) with 0.5%, 5%, or 10% FCS. After incubation for 48 hours, the medium was removed, and ice-cold 10% TCA was added for 30 minutes at 4°C. After 2 rinses with cold 10% TCA, the acid-precipitable material was solubilized for 2 hours in 0.5 mL of 0.3N NaOH with 0.1% sodium dodecylsulfate at 37°C. Incorporated radioactivity (in counts per minute) in the remaining cell lysate was measured with a liquid scintillation counter. All experiments were run in 4 replicates.
Chemicals
Tritiated thymidine was from Amersham Pharmacia Biotech (Buckingham, United Kingdom). Tritiated proline was from NEN, PerkinElmer Life Sciences (Courtaboeuf, France). The primary and secondary antibodies used for immunofluorescence analyses were purchased from Dako (DakoCytomation S.A.S., Trappes, France) and Jackson Immunoresearch Inc (Cambridgeshire, United Kingdom), respectively. Antibiotics were from Laboratoires Diamant (Paris, France) and Pharmacia (Saint-Quentin-en-Yvelines, France). FCS, DMEM, and PBS were from Invitrogen (Cergy Pontoise, France). We used the same lot of FCS for the entire experiment. Formaldehyde, xylene, triton, hematoxylin and eosin, elastic stain, orcein-picroindigo-carmine, and gelatin were from Sigma-Aldrich (Sigma-Aldrich Chimie, Lyon, France).
Statistical Analysis
Statistical analysis was performed with SPSS Base 11.5 statistical software (SPSS Inc, Chicago, Ill). All data are reported as means ± standard error of the mean. Analysis of variance was used for between-group comparisons. When analysis of variance showed a significant difference, the groups were compared with a Mann-Whitney nonparametric test.
| Results |
|---|
|
|
|---|
-smooth muscle actin, desmin, and vimentin showed predominant involvement of SMCs in neointimal growth induced by organ culture of SV rings (Figure 2).
|
|
|
|
|
| Discussion |
|---|
|
|
|---|
NIH is a disease process that occurs early after grafting and affects both venous and arterial grafts.
4
Although it can be viewed as adaptive, it might also predispose the graft to later accelerated graft atherosclerosis.
15
In the present study, culturing vessel rings with FCS induced NIH development in all 3 types of vessels used for CABG. However, NIH was significantly less pronounced in ITA and RA rings than in SV rings. These results are in accordance with previous studies of human bypass graft cultures showing greater NIH severity in SV rings than in ITA rings
16,17
and RA rings.
17
Cable and colleagues
17
have shown that organ culture of ITA and RA vascular rings for up to 14 days was not associated with significant NIH. Vascular structure is known to influence NIH development: elastic arteries are less prone to NIH than are muscular arteries.
18
The ITA has a mainly elastic media with few SMCs and a dense internal elastic lamina with few fenestrations. This might be an important barrier to SMC migration and might therefore reduce the development of NIH.
1
In contrast, the highly fenestrated structure of the internal elastic lamina of SV grafts and the thick and muscular media of RA grafts might promote the development of NIH.
18
However, there was no significant difference in NIH development between RA and ITA rings in our study.
It is generally accepted that NIH involves proliferation of SMCs in the media of the graft. These proliferating cells subsequently migrate into the graft intima, where they undergo further division and secrete extracellular matrix.
19
Our organ culture model is in accordance with this pathogenic concept, as demonstrated by the major presence of SMCs with immunofluorescence analyses. SMC proliferation and migration are complex processes regulated by multiple stimulatory and inhibitory influences. Differences in endothelial function, inherent properties of SMCs, or both, might explain our findings. However, although organ culture of vascular rings maintains the anatomic relationships among cells of the vascular wall, several other variables that participate in vivo are known to contribute to NIH (including circulating cells, hemodynamic factors, flow, and size mismatch between the conduit and the recipient artery) and are not taken into account by this model. In addition, the response to FCS might not represent the response seen in vivo. Therefore our findings might not be extrapolated to the clinical setting.
The vascular endothelium has important regulatory effects on vascular-wall remodeling.
20
Several endothelium-derived mediators influence vascular SMC proliferation and migration. Thus, agents that increase SMC cyclic adenosine monophosphate concentrations (prostaglandins E1 and I2) or cyclic guanosine monophosphate concentrations (nitric oxide) have been shown to inhibit vascular SMC proliferation.
21,22
ITAs release more prostaglandin I2 and show greater nitric oxidemediated endothelium-dependent relaxation than SVs.
1
Furthermore, He and Liu
23
recently showed that basal and stimulated levels of nitric oxide release in human ITAs were significantly greater than those seen in RAs. This lower capacity for nitric oxide release might contribute to the susceptibility of RAs to perioperative vasospasm and might also influence the long-term patency of RA grafts by greater SMC proliferation and migration.
Alternatively, the differences in NIH across vessels could be related to differences in the inherent properties of their SMCs. Indeed, the phenotypic heterogeneity of vascular SMCs is now well established,
11
and differences in proliferation and migratory properties might translate into dissimilar propensities of blood vessels to exhibit NIH. The results of our cell-culture experiments suggest that SMCs from ITAs and RAs might be more resistant to mitogenic stimulation by FCS than those from SVs, suggesting a greater propensity of SVs to enter a proliferative state. Yang and coworkers
24
have shown that SMCs from SVs exhibit a higher rate of serum-induced explant outgrowth and tritiated thymidine incorporation compared with ITA SMCs. White and associates
25
also evidenced a stronger tritiated thymidine incorporation response to platelet-derived growth factor (PDGF) in human SV-derived cells compared with that seen in ITA-derived cells. However, only limited data are available on the proliferative capacity of SMCs from RAs compared with those from ITAs, SVs, or both. Del Rizzo and coworkers
26
reported significantly less tritiated thymidine uptake after stimulation with the PDGF-BB homodimer in SMCs from ITAs and RAs compared with those from SVs. The same investigators found higher levels of c-fos expression (an oncoprotein regulating cell proliferation and differentiation) both constitutively and after PDGF-BB stimulation in SMCs from SVs. These data suggest that SV SMCs might have a greater propensity to enter into a proliferative state compared with SMCs from RAs or ITAs. In contrast to Del Rizzo and coworkers,
26
we found that the proliferative response to FCS was significantly stronger in RA SMCs than in ITA SMCs. However, as noted above, this did not translate into increased NIH generation in RA rings compared with that seen in ITA rings. Considering the limited NIH production in arterial vascular grafts,
17
longer incubation periods (>14 days) might be necessary to show significant differences between RA and ITA vascular rings. The increased inherent propensity of RA SMCs to proliferate might explain, in addition to the previously mentioned lower nitric oxide release, the higher incidence of NIH at harvesting
27,28
and the consistently lower long-term patency rates of RA grafts compared with left-sided ITA grafts in vivo.
7
In addition to a diminished proliferative response of arterial SMCs exposed to mitogens, we found significant reductions in arterial SMC migration compared with that seen in SV SMCs. Matrix metalloproteases (MMPs) are required for NIH development, mainly because of their effects on SMC migration. Anstadt and associates
29
recently reported significantly reduced MMP-2 levels and activity in ITA grafts compared with that seen in SV grafts. Whether MMP expression in RA grafts is similar to that in ITA grafts remains to be determined. However, we found no differences in migratory properties between RA SMCs and ITA SMCs in the present study.
We observed no significant differences in collagen synthesis between SV-, ITA-, and RA-derived SMCs. This observation lies in contrast with the recent report by Wong and colleagues,
30
who found that venous SMCs are more dedifferentiated and demonstrate increased proliferation, migration, and synthetic capacity compared with arterial SMCs in serum-stimulated culture conditions. However, these authors used rabbit SMCs originating from carotid and jugular veins, and SMC behavior might vary in different vascular beds and species.
In conclusion, the human SV has a greater propensity for NIH formation than arterial grafts, with increased intrinsic proliferative and migratory properties of venous SMCs. In contrast, we found no significant differences in NIH formation between ITA and RA grafts, despite significantly increased proliferative properties of RA-derived SMCs.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
Y. Cai, W. E. Knight, S. Guo, J.-D. Li, P. A. Knight, and C. Yan Vinpocetine Suppresses Pathological Vascular Remodeling by Inhibiting Vascular Smooth Muscle Cell Proliferation and Migration J. Pharmacol. Exp. Ther., November 1, 2012; 343(2): 479 - 488. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Cai, C. L. Miller, D. J. Nagel, K.-I. Jeon, S. Lim, P. Gao, P. A. Knight, and C. Yan Cyclic Nucleotide Phosphodiesterase 1 Regulates Lysosome-Dependent Type I Collagen Protein Degradation in Vascular Smooth Muscle Cells Arterioscler Thromb Vasc Biol, March 1, 2011; 31(3): 616 - 623. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kundi, S. T. Hollenbeck, D. Yamanouchi, B. C. Herman, R. Edlin, E. J. Ryer, C. Wang, S. Tsai, B. Liu, and K. C. Kent Arterial gene transfer of the TGF-{beta} signalling protein Smad3 induces adaptive remodelling following angioplasty: a role for CTGF Cardiovasc Res, November 1, 2009; 84(2): 326 - 335. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. H. Walpoth, M. Schmid, A. Schwab, A. Bosshard, F. Eckstein, T. Carrel, and O. M. Hess Vascular adaptation of the internal thoracic artery graft early and late after bypass surgery. J. Thorac. Cardiovasc. Surg., October 1, 2008; 136(4): 876 - 883. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G.M. Molin and M. J. Post Do intrinsic arterial wall features determine atherosclerosis susceptibility? Cardiovasc Res, October 1, 2006; 72(1): 3 - 4. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |